Validation of Dementia-Free Status in the Iranian Brain Imaging Database Using Adni Data: A Transition Point From Middle Age to Older Adulthood Publisher Pubmed



S Ghaderi SADEGH ; S Mohammadi SANA ; F Fatehi FARZAD ; M Sisakhti MINOO ; Sah Batouli Seyed Amir HOSSEIN
Source: BMC Neurology Published:2025

Abstract

Objective: To validate the Iranian Brain Imaging Database (IBID) for dementia-free status in middle-aged to older adults (over 55 years old) by comparing dementia probability metrics with Alzheimer’s disease (AD) patients from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Methods: This cross-sectional study included 41 cognitively normal participants from IBID (age > 55 years; median (IQR) = 64 (62, 68) years; females = 51.2%) and 41 age/sex-matched AD patients from ADNI (age > 55 years; median (IQR) = 69 (62, 71) years; females = 53.7%). High-resolution 3D T1-weighted MPRAGE MRI data were harmonized across Siemens 3.0 Tesla scanners, preprocessed via the AssemblyNet-AD pipeline (volBrain), and analyzed for grading scores and hippocampal-amygdalo-ventricular atrophy scores (HAVAs), along with hippocampus, amygdala, and inferior lateral ventricle atrophy scores. Non-parametric Mann–Whitney U tests were used to compare group differences, and quantile regression (25th, 50th, and 75th quantiles) model atrophy severity-dependent associations. Results: IBID participants exhibited minimal dementia probability (median grading score = 0.20% vs. ADNI = 99.93%; U = 84.0, p < 0.0001) and markedly lower atrophy across all regions (HAVAs: 14.76 vs. 86.41; U = 75.0, p < 0.0001), with non-overlapping interquartile ranges. Quantile regression revealed stable hippocampal contributions (q₀.₅ coefficient = 0.311, p < 0.001) and increasing group disparities at higher atrophy severities (q₀.₇₅: IBID vs. ADNI coefficient = − 11.82, p < 0.001). Conclusion: We provided validated dementia-free IBID neuroimaging data to distinguish normal aging from dementia-AD status. © 2025 Elsevier B.V., All rights reserved.